Search - tctmd.com

Displaying 21 - 40 of 70

Sort: Relevancy | Date

Presentation TVT 2023

Summit Trial (Tendyne)

Presenter: Jason Rogers

June 09, 2023

Presentation TCT 2022

SUMMIT Trial (Tendyne)

Presenter: Jason H. Rogers

September 18, 2022

Presentation TCT 2022

Tendyne – SUMMIT MAC Cohort

Presenter: Gorav Ailawadi

September 17, 2022

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

News Daily News

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Yael L. Maxwell

November 03, 2021

Presentation TVT 2021

The SUMMIT Tendyne Trial: Changing the Paradigm of MR Treatment

Presenter: Jason Rogers

July 21, 2021

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Daily News

European Regulators Approve First Transcatheter MV Replacement Device

Michael O'Riordan

January 30, 2020

Presentation TCT 2019

Transapical II: Tendyne — Device Description, Results, and Ongoing Studies

Presenter: Jason Rogers

September 28, 2019

News Daily News

Early Signs Positive for Tendyne TMVR in Severe MAC

Caitlin E. Cox

September 11, 2019

News Featured Fellow

Shane Prejean, MD

Yael L. Maxwell

August 20, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

Presentation TVT 2019

TENDYNE: Attributes, Challenges, and Clinical Data (SUMMIT)

Presenter: Gorav Ailawadi

June 14, 2019

Presentation EuroPCR 2019

Mitral regurgitation severity predicts one year therapeutic benefit of Tendyne transcatheter mitral valve implantation

Presenter: Vinay Badhwar

May 22, 2019

News Industry News

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

November 06, 2018

Presentation TCT 2018

Tendyne: Device Attributes, Implant Procedure, Clinical Results and SUMMIT Design and Status

Presenter: Michael J. Mack, David W.M. Muller, Gorav Ailawadi

September 24, 2018

Presentation TCT 2018

TENDYNE Transcatheter Mitral Prosthesis: Long-term Results From the First 100 Patients Enrolled in the Global Feasibility Study

Presenter: Charles J. Davidson, Francesco Maisano, Paul Sorajja

September 24, 2018

Presentation The Structural Heart Disease Summit 2018

The TENDYNE Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT)

Presenter: Rashmi Yadav

June 22, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Shelley Wood

March 07, 2018

Advertisement

Summit Trial (Tendyne)

SUMMIT Trial (Tendyne)

Tendyne – SUMMIT MAC Cohort

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

The SUMMIT Tendyne Trial: Changing the Paradigm of MR Treatment

Implantation Technique Influences LV Remodeling After TMVR

European Regulators Approve First Transcatheter MV Replacement Device

Transapical II: Tendyne — Device Description, Results, and Ongoing Studies

Early Signs Positive for Tendyne TMVR in Severe MAC

Shane Prejean, MD

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

TENDYNE: Attributes, Challenges, and Clinical Data (SUMMIT)

Mitral regurgitation severity predicts one year therapeutic benefit of Tendyne transcatheter mitral valve implantation

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

Tendyne: Device Attributes, Implant Procedure, Clinical Results and SUMMIT Design and Status

TENDYNE Transcatheter Mitral Prosthesis: Long-term Results From the First 100 Patients Enrolled in the Global Feasibility Study

The TENDYNE Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT)

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content